12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

to-BBB preclinical data

to-BBB plans to start a Phase I trial of the glutathione pegylated liposomal methylprednisolone next year. The Dutch government agency Agentschap NL granted to-BBB a €500,000 ($611,351) Innovation Credit for preclinical development of 2B3-201, with an option to apply for additional credits...

Read the full 189 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >